Migraine sufferers have new oral medication with FDA approval of Allergan's Ubrelvy
December 26, 2019 at 11:03 AM EST
Ubrelvy is proven to ease migraine symptoms in two hours.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|